DNA vs. INVZ
DNA (Ginkgo Bioworks Holdings, Inc.) and INVZ (Innoviz Technologies Ltd.) are both stocks. DNA operates in Biotechnology (Healthcare), while INVZ operates in Auto Parts (Consumer Cyclical). Over the past 5 years, DNA returned -54.05%/yr vs -45.89%/yr for INVZ. Their 0.39 correlation means their historical movements had little consistent relationship.
Performance
DNA vs. INVZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DNA achieves a -2.65% return, which is significantly higher than INVZ's -49.71% return.
DNA
- 1D
- 0.00%
- 1M
- -22.21%
- 6M
- -9.81%
- YTD
- -2.65%
- 1Y
- -33.63%
- 3Y*
- -55.79%
- 5Y*
- -54.05%
- 10Y*
- —
- ALL TIME*
- -52.75%
INVZ
- 1D
- 1.85%
- 1M
- -38.07%
- 6M
- -55.39%
- YTD
- -49.71%
- 1Y
- -71.01%
- 3Y*
- -52.61%
- 5Y*
- -45.89%
- 10Y*
- —
- ALL TIME*
- -44.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $5.54M | $7.53M | $10.61M | |
| $1.96M | $1.54M | $2.22M |
DNA vs. INVZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DNA Ginkgo Bioworks Holdings, Inc. | -2.65% | -15.38% | -85.47% | 0.00% | -79.66% | -21.68% |
INVZ Innoviz Technologies Ltd. | -49.71% | -49.22% | -33.60% | -35.62% | -38.01% | -37.17% |
Correlation
The correlation between DNA and INVZ is 0.33, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.33 |
Correlation (3Y) Balances recent behavior with more history. | 0.37 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.40 |
Correlation (All Time) Calculated using the full available price history since Apr 19, 2021 | 0.39 |
Fundamentals
DNA:
$528.48M
INVZ:
$94.97M
DNA:
-$5.35
INVZ:
-$0.39
DNA:
3.78
INVZ:
2.01
DNA:
1.09
INVZ:
1.55
DNA:
$121.84M
INVZ:
$44.83M
DNA:
$99.27M
INVZ:
$4.34M
DNA:
-$218.90M
INVZ:
-$73.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DNA vs. INVZ — Risk / Return Rank
DNA
INVZ
DNA vs. INVZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Innoviz Technologies Ltd. (INVZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DNA | INVZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.37 | ||
| Sortino ratioReturn per unit of downside risk | +1.30 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 0.85 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.58 | -0.86 | +0.28 |
| Martin ratioReturn relative to average drawdown | -0.92 | -1.31 | +0.39 |
Loading charts...
Drawdowns
DNA vs. INVZ - Drawdown Comparison
The maximum DNA drawdown since its inception was -99.10%, roughly equal to the maximum INVZ drawdown of -96.92%. Use the drawdown chart below to compare losses from any high point for DNA and INVZ.
Loading charts...
Drawdown Indicators
| DNA | INVZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.10% | -96.92% | -2.18% |
Max Drawdown (1Y)Largest decline over 1 year | -66.05% | -84.03% | +17.98% |
Max Drawdown (3Y)Largest decline over 3 years | -94.27% | -89.76% | -4.51% |
Max Drawdown (5Y)Largest decline over 5 years | -99.10% | -96.02% | -3.08% |
Current DrawdownCurrent decline from peak | -98.64% | -96.53% | -2.11% |
Average DrawdownAverage peak-to-trough decline | -80.34% | -75.37% | -4.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.00% | 55.26% | -13.26% |
Volatility
DNA vs. INVZ - Volatility Comparison
The current volatility for Ginkgo Bioworks Holdings, Inc. (DNA) is 20.16%, while Innoviz Technologies Ltd. (INVZ) has a volatility of 43.07%. This indicates that DNA experiences smaller price fluctuations and is considered to be less risky than INVZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DNA | INVZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.16% | 43.07% | -22.91% |
Volatility (6M)Calculated over the trailing 6-month period | 71.47% | 67.49% | +3.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.26% | 92.96% | +0.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.50% | 91.13% | +7.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.79% | 90.01% | +5.78% |
Dividends
DNA vs. INVZ - Dividend Comparison
Neither DNA nor INVZ has paid dividends to shareholders.
Financials
DNA vs. INVZ - Financials Comparison
This section allows you to compare key financial metrics between Ginkgo Bioworks Holdings, Inc. and Innoviz Technologies Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DNA and INVZ have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVZ has higher volatility (43.07%) compared to DNA (20.16%). In terms of maximum drawdown, DNA dropped -99.10% vs INVZ's -96.92%.
DNA currently has the higher Sharpe Ratio (-0.41 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DNA and INVZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer